Q9UNN8 (EPCR_HUMAN) Homo sapiens (Human)
Endothelial protein C receptor UniProtKBInterProSTRINGInteractive Modelling
238 aa; Sequence (Fasta)
Available Structures
12 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of the Endothelial protein C receptor with phospholipid in the groove in complex … |
Heteromer P04070; | 3×NAG; 1×PTY; 7×CA; | ||||
Assess | ||||||
Importance of Mg2+ in the Ca2+-Dependent Folding of the gamma-Carboxyglutamic Acid Domains of Vitam… |
Heteromer P04070; | 3×NAG; 1×PTY; 2×MG; 5×CA; | ||||
Assess | ||||||
The CIDRa domain from IT4var07 PfEMP1 bound to endothelial protein C receptor |
Heteromer | 1×NAG; 1×NAG; 1×PTY; 2×NAG; | ||||
Assess | ||||||
Synthetic mimic of an EPCR-binding PfEMP1 bound to EPCR |
Heteromer | 2×NAG; 1×NAG; 1×PTY; | ||||
Assess | ||||||
The CIDRa domain from HB3var03 PfEMP1 bound to endothelial protein C receptor |
Heteromer | 2×NAG; 1×NAG; 1×PTY; 1×NAG; | ||||
Assess | ||||||
HB3VAR03 apo headstructure (PfEMP1 A) complexed with EPCR |
Heteromer A0A0L7KL67; | 1×PTY; 1×NAG; | ||||
Assess | ||||||
Structure of EPCR in a non-canonical conformation | monomer | 2×NAG; 1×CYS; 1×PTY; 1×GOL; | ||||
Assess | ||||||
X-ray structure of soluble EPCR in P3121 space group | monomer | 2×NAG; 1×NAG; 2×EDO; 1×PTY; | ||||
Assess | ||||||
X-ray structure of soluble EPCR in P212121 space group | monomer | 1×NAG; 2×NAG; 1×PTY; 1×EDO; | ||||
Assess | ||||||
Crystal Structure of the Endothelial Protein C Receptor and Bound Phospholipid Molecule | monomer | 2×NAG; 1×NAG; 1×PTY; | ||||
Assess | ||||||
Crystal structure of soluble EPCR after exposure to the nonionic surfactant Polysorbate 20 | monomer | 3×NAG; 1×R16; 1×HEX; 1×D10; 1×EDO; | ||||
Assess | ||||||
X-ray structure of soluble EPCR in C2221 space group | monomer | 3×NAG; 1×EDO; 1×PTY; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
3jtc.2.A | monomer | 0.86 | 1×PTY; | 100.00 | ||
Assess |